Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI raises $115m to fund drug development

BenevolentAIIts technology could cut the early stage drug discovery process by four years, says the company

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

Merck KGaAWill also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range

Rigel and Ultragenyx claim approvals for rare drugs

Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively

Sanofi sells European generics to Advent for $2.4bn

Sanofi receptionThe deal will create a new, independent European generics company

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

Bayer symbol

Abeona Therapeutics names CEO

Carsten Thiel joins the biopharma from Alexion

Appointment

No results were found

Zelluna Immunotherapy appoints chief technology officer

Arjan Roozen will consolidate the biotech’s manufacturing strategy

Appointment

Investing in digital could 'unlock £22bn' for UK pharma

Accenture outlines tech's revenue-growth and cost-saving potential

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics